Ioannis Andreou1, Saeko Takahashi2, Masaya Tsuda3, Koki Shishido2, Antonios P Antoniadis4, Michail I Papafaklis4, Shingo Mizuno2, Ahmet U Coskun5, Shigeru Saito2, Charles L Feldman4, Elazer R Edelman1, Peter H Stone6. 1. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA. 2. Department of Cardiovascular Medicine, Shonan Kamakura General Hospital, Kanagawa, Japan. 3. Department of Cardiovascular Medicine, Hokkaido University, Sapporo, Japan. 4. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 5. Mechanical and Industrial Engineering, Northeastern University, Boston, MA, USA. 6. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: pstone@partners.org.
Abstract
BACKGROUND AND AIMS: The natural history and the role of atherosclerotic plaque located behind the stent (PBS) are still poorly understood. We evaluated the serial changes in PBS following bare-metal (BMS) compared to first-generation drug-eluting stent (DES) implantation and the impact of these changes on in-stent neointimal hyperplasia (NIH). METHODS: Three-dimensional coronary reconstruction by angiography and intravascular ultrasound was performed after intervention and at 6-10-month follow-up in 157 patients with 188 lesions treated with BMS (n = 89) and DES (n = 99). RESULTS: There was a significant decrease in PBS area (-7.2%; p < 0.001) and vessel area (-1.7%; p < 0.001) after BMS and a respective increase in both areas after DES implantation (6.1%; p < 0.001 and 4.1%; p < 0.001, respectively). The decrease in PBS area significantly predicted neointimal area at follow-up after BMS (β: 0.15; 95% confidence interval [CI]: 0.10-0.20, p < 0.001) and DES (β: 0.09; 95% CI: 0.07-0.11; p < 0.001) implantation. The decrease in PBS area was the most powerful predictor of significant NIH after BMS implantation (odds ratio: 1.13; 95% CI: 1.02-1.26; p = 0.02). CONCLUSIONS: The decrease in PBS area after stent implantation is significantly associated with the magnitude of NIH development at follow-up. This finding raises the possibility of a communication between the lesion within the stent and the underlying native atherosclerotic plaque, and may have important implications regarding the pathobiology of in-stent restenosis and late/very late stent thrombosis.
BACKGROUND AND AIMS: The natural history and the role of atherosclerotic plaque located behind the stent (PBS) are still poorly understood. We evaluated the serial changes in PBS following bare-metal (BMS) compared to first-generation drug-eluting stent (DES) implantation and the impact of these changes on in-stent neointimal hyperplasia (NIH). METHODS: Three-dimensional coronary reconstruction by angiography and intravascular ultrasound was performed after intervention and at 6-10-month follow-up in 157 patients with 188 lesions treated with BMS (n = 89) and DES (n = 99). RESULTS: There was a significant decrease in PBS area (-7.2%; p < 0.001) and vessel area (-1.7%; p < 0.001) after BMS and a respective increase in both areas after DES implantation (6.1%; p < 0.001 and 4.1%; p < 0.001, respectively). The decrease in PBS area significantly predicted neointimal area at follow-up after BMS (β: 0.15; 95% confidence interval [CI]: 0.10-0.20, p < 0.001) and DES (β: 0.09; 95% CI: 0.07-0.11; p < 0.001) implantation. The decrease in PBS area was the most powerful predictor of significant NIH after BMS implantation (odds ratio: 1.13; 95% CI: 1.02-1.26; p = 0.02). CONCLUSIONS: The decrease in PBS area after stent implantation is significantly associated with the magnitude of NIH development at follow-up. This finding raises the possibility of a communication between the lesion within the stent and the underlying native atherosclerotic plaque, and may have important implications regarding the pathobiology of in-stent restenosis and late/very late stent thrombosis.
Authors: Kengo Tanabe; Patrick W Serruys; Muzaffer Degertekin; Giulio Guagliumi; Eberhard Grube; Charles Chan; Thomas Munzel; Jorge Belardi; Witold Ruzyllo; Luc Bilodeau; Henning Kelbaek; John Ormiston; Keith Dawkins; Louis Roy; Bradley H Strauss; Clemens Disco; Jörg Koglin; Mary E Russell; Antonio Colombo Journal: Circulation Date: 2003-12-22 Impact factor: 29.690
Authors: Ahmet U Coskun; Yerem Yeghiazarians; Scott Kinlay; Maureen E Clark; Olusegun J Ilegbusi; Andreas Wahle; Milan Sonka; Jeffrey J Popma; Richard E Kuntz; Charles L Feldman; Peter H Stone Journal: Catheter Cardiovasc Interv Date: 2003-09 Impact factor: 2.692
Authors: G S Mintz; J J Popma; A D Pichard; K M Kent; L F Salter; Y C Chuang; J Griffin; M B Leon Journal: J Am Coll Cardiol Date: 1996-06 Impact factor: 24.094
Authors: Kazuyuki Yahagi; Frank D Kolodgie; Fumiyuki Otsuka; Aloke V Finn; Harry R Davis; Michael Joner; Renu Virmani Journal: Nat Rev Cardiol Date: 2015-10-27 Impact factor: 32.419